Please call your physician’s office before coming in for your appointment if you have symptoms of a cough, fever, or difficulty breathing; traveled to Europe or China or other areas impacted by the coronavirus (COVID-19) within the past 14 days; been in close contact with someone who has traveled outside the U.S. to one of the impacted countries; or may have been exposed to the coronavirus.  For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Our new office hours are: Monday through Friday 8:30 a.m. to 4:00 p.m, if you have an appointment scheduled for after hours, our office will be contacting you directly to reschedule. FOR THE LATEST UP TO DATE INFORMATION, ALERTS AND CANCELLATIONS PLEASE CLICK HERE

Daniel Chong, MD

VCS Physicians

Daniel Chong, MD Headshot

At the heart of every cancer patient, is that they are being care for. Here at Virginia Cancer Specialists we provide both personalized and compassionate care.

Work and Credentials:

Primary Location

Fairfax Office

Position

Medical Oncologist

Board Certification

Medical Oncology and Internal Medicine

Fellowship

University of California, Los Angeles, Medical Oncology and Hematology

Internship

Medical College of Georgia at Georgia Regents University

Residency

Medical College of Georgia at Georgia Regents University

Medical School

University of Virginia School of Medicine

College

University of Virginia

Daniel G. Chong, M.D. attended the University of Virginia where he graduated with a Bachelors of Science in Biochemistry. He earned his medical degree from the University of Virginia School of Medicine, then went on to complete his residency and internship at the Medical College of Georgia at Georgia Regents University. While there, he served as Chief Medical Resident and won the Rahn-Peacock Research Award among other academic honors.

Dr. Chong joins Virginia Cancer Specialists after serving as Chief Fellow in the Medical Oncology and Hematology Fellowship program at the David Geffen School of Medicine at UCLA. During his time there, Dr. Chong was also a Clinical Research Fellow at the Jonsson Comprehensive Cancer Center, where he participated in various studies, including several focused on prostate cancer. He has presented posters at national physician conferences and has authored several peer-reviewed publications. Dr. Chong is a member of both the American Society of Hematology and the American Society of Clinical Oncology.

In his spare time, Dr. Chong enjoys running and spending time with his family, including his three daughters.

 

 

Clinical Trials (2)

Clinical Trial 17-214-09

A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma


Clinical Trial 17-005

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

Primary Location

Fairfax Office Office

Fairfax Office

Learn More

Other Locations